These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 18081906)

  • 1. Is poor glycaemic control in diabetic patients a risk factor of myopia?
    Jacobsen N; Jensen H; Lund-Andersen H; Goldschmidt E
    Acta Ophthalmol; 2008 Aug; 86(5):510-4. PubMed ID: 18081906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of glycaemic control in patients with Type 1 diabetes commencing continuous subcutaneous insulin infusion therapy.
    Shalitin S; Gil M; Nimri R; de Vries L; Gavan MY; Phillip M
    Diabet Med; 2010 Mar; 27(3):339-47. PubMed ID: 20536498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continued reduction in the prevalence of retinopathy in adolescents with type 1 diabetes: role of insulin therapy and glycemic control.
    Downie E; Craig ME; Hing S; Cusumano J; Chan AK; Donaghue KC
    Diabetes Care; 2011 Nov; 34(11):2368-73. PubMed ID: 22025782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between self-monitoring of blood glucose control and glycosylated haemoglobin in patients with type 2 diabetes with and without diabetic retinopathy.
    Ozmen B; Boyvada S
    J Diabetes Complications; 2003; 17(3):128-34. PubMed ID: 12738396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of insulin therapy in patients with type 2 diabetes mellitus: beyond basal insulin.
    Blak BT; Smith HT; Hards M; Curtis BH; Ivanyi T
    Diabet Med; 2012 Jul; 29(7):e13-20. PubMed ID: 22268988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refractive Error and Retinopathy Outcomes in Type 1 Diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.
    Hainsworth DP; Gao X; Bebu I; Das A; Olmos de Koo L; Barkmeier AJ; Tamborlane W; Lachin JM; Aiello LP;
    Ophthalmology; 2021 Apr; 128(4):554-560. PubMed ID: 32941962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early glycemic control, age at onset, and development of microvascular complications in childhood-onset type 1 diabetes: a population-based study in northern Sweden.
    Svensson M; Eriksson JW; Dahlquist G
    Diabetes Care; 2004 Apr; 27(4):955-62. PubMed ID: 15047655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study.
    Yurgin N; Secnik K; Lage MJ
    Clin Ther; 2007 Feb; 29(2):316-25. PubMed ID: 17472823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved glycemic control with use of continuous subcutaneous insulin infusion compared with multiple insulin injection therapy.
    Bell DS; Ovalle F
    Endocr Pract; 2000; 6(5):357-60. PubMed ID: 11141585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of glycaemic control in type 1 diabetes during intensified therapy with multiple daily insulin injections or continuous subcutaneous insulin infusion: importance of blood glucose variability.
    Pickup JC; Kidd J; Burmiston S; Yemane N
    Diabetes Metab Res Rev; 2006; 22(3):232-7. PubMed ID: 16389648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refractive error in Chinese with type 2 diabetes and its association with glycaemic control.
    Song E; Qian DJ; Wang S; Xu C; Pan CW
    Clin Exp Optom; 2018 Mar; 101(2):213-219. PubMed ID: 28975669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glargine is superior to neutral protamine Hagedorn for improving glycated haemoglobin and fasting blood glucose levels during intensive insulin therapy.
    Fulcher GR; Gilbert RE; Yue DK
    Intern Med J; 2005 Sep; 35(9):536-42. PubMed ID: 16105155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 4 years subcutaneous insulin infusion treatment on albuminuria, kidney function and HbA1c compared with multiple daily injections: a longitudinal follow-up study.
    Rosenlund S; Hansen TW; Andersen S; Rossing P
    Diabet Med; 2015 Nov; 32(11):1445-52. PubMed ID: 26331364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycemic Variability and Diabetes Complications: Does It Matter? Of Course It Does!
    Hirsch IB
    Diabetes Care; 2015 Aug; 38(8):1610-4. PubMed ID: 26207054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refractive errors in type 2 diabetic patients.
    Mwale C; Karimurio J; Njuguna M
    East Afr Med J; 2007 Jun; 84(6):259-63. PubMed ID: 18254467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemoglobin Glycosylation Index is not related with blood glucose.
    Merino-Torres JF; Fajardo-Montañana C; Ferrer-García JC; Piñón-Sellés F
    J Diabetes Complications; 2003; 17(5):249-53. PubMed ID: 12954152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control.
    Zhang L; Krzentowski G; Albert A; Lefebvre PJ
    Diabetes Care; 2001 Jul; 24(7):1275-9. PubMed ID: 11423515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Prior Intensive Insulin Therapy and Risk Factors on Patient-Reported Visual Function Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort.
    ; Gubitosi-Klug RA; Sun W; Cleary PA; Braffett BH; Aiello LP; Das A; Tamborlane W; Klein R
    JAMA Ophthalmol; 2016 Feb; 134(2):137-45. PubMed ID: 26584339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes care, glycemic control, and complications in children with type 1 diabetes from Asia and the Western Pacific Region.
    Craig ME; Jones TW; Silink M; Ping YJ
    J Diabetes Complications; 2007; 21(5):280-7. PubMed ID: 17825751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 6-year nationwide cohort study of glycaemic control in young people with type 1 diabetes. Risk markers for the development of retinopathy, nephropathy and neuropathy. Danish Study Group of Diabetes in Childhood.
    Olsen BS; Sjølie A; Hougaard P; Johannesen J; Borch-Johnsen K; Marinelli K; Thorsteinsson B; Pramming S; Mortensen HB
    J Diabetes Complications; 2000; 14(6):295-300. PubMed ID: 11120452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.